Clinical Trials
8 trialsNCT01231412 2026-04-30
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT02730299 2026-02-25
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
Phase 3 Completed
NCT02999854 2022-05-24
HATCY
Kiadis Pharma
Phase 3 Terminated
NCT03800095 2021-03-24
CALVI
University Hospital, Clermont-Ferrand
Phase 3 Unknown
NCT00790036 2017-07-12
PILLAR2
Novartis
Phase 3 Completed
NCT00075478 2017-05-15
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT01217723 2010-10-08
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation
McMaster University
Phase 3 Unknown
NCT00884364 2009-12-23
Exercise During Chemotherapy for Patients With Hematological Malignancies
Charite University, Berlin, Germany
Phase 3 Unknown